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Abstract
The purpose of this study was to determine if feeding dogs medium-chain triglycerides (MCT), fish oil, and L-carnitine
enriched foods offsets age-associated changes in serum fatty acids (FA) and carnitine metabolites. Forty-one healthy
Beagles, mean age 9.9 years (range 3.1 to 14.8), were fed control or one of two treatment foods for 6 months. All foods were
complete and balanced and met the nutrient requirements for adult dogs, and had similar concentrations of moisture,
protein, and fat (approx. 7.4%, 14.0%, and 18.1%, respectively). The treatment diets both contained added L-carnitine
(300 mg/kg) and 0.6% (treatment food 1) or 1.5% (treatment food 2) added fish oil. Treatment food 2 also had increased
MCT from coconut oil, added corn oil, and reduced animal fat. Composition of serum FA was determined by gas
chromatography of FA methyl esters. Metabolomic profiles of serum samples were determined from extracted supernatants
that were split and run on GC/MS and LC/MS/MS platforms, for identification and relative quantification of small
metabolites. Body composition was determined by dual energy x-ray absorptiometry. Among dog groups, there was no
change in total-lean-body weight, or in serum total protein and serum albumin concentrations, based on time or dietary
treatment. Serum concentrations of carnitine metabolites were decreased in geriatric (.7 years) vs. mature adult (#7 years)
dogs, and supplementation with L-carnitine attenuated the effects of aging. The ratio of PUFA to SFA was significantly
greater in mature dogs at baseline (P#0.05). Serum concentrations of eicosapentaenoic and docosahexaenoic FA increased
in a dose-dependent manner. Dogs consuming treatment food 2 also had increased serum concentrations of lauric and
myristic FA, and decreased concentrations of SFA, MUFA, and arachidonate (all P#0.05) and their PUFA to SFA ratio
increased. In summary, dietary MCT, fish oil, and L-carnitine counterbalanced the effects of aging on circulating
concentrations of these compounds.
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Introduction
Nutritional intervention with dietary supplements offers a
means of altering the age-related decline in energy metabolism
that is recognized in older animals (reviewed in [1]). Carnitine is a
necessary nutrient in energy production and its content decreases
with aging [2,3]. Carnitine performs an obligate role in
mitochondrial oxidation of long-chain fatty acids (FA) through
the action of specialized acyltransferases [4]. Briefly, L-carnitine is
needed to transport long-chain FA from the cytosol to sites of beta-
oxidation in the mitochondria. Acetate is the by-product of beta-
oxidation and provides usable energy via the citric acid cycle.
Under normal conditions, the availability of carnitine is not a
limiting step in beta-oxidation, although an increase in carnitine
content may increase the rate of FA oxidation, permitting a
reduction of glucose utilization, preserving muscle glycogen
content, and ensuring maximal rates of oxidative ATP production
[5]. Older dogs with age-related progressive renal dysfunction may
be polyuric and uremic. Loss of carnitine through dialytic
membranes has been documented in hemodialysis patients with
end-stage kidney disease, resulting in potential carnitine depletion
[6]. Carnitine supplementation has been shown to counteract such
alterations and may be associated with improvements in metabolic
and clinical complications seen in uremic patients (reviewed in
[6,7]).
Serum levels of specific FA are negatively correlated with age in
humans [8]. In a large (n=1123) community-based study of
persons aged 20 to 98 years, mean plasma concentration of total
FA tended to be higher at older ages, yet the percentage of (n-3)
and (n-6) FA were significantly lower in older participants, which
may explain the mild proinflammatory state that is often found in
the elderly [8].
Fat is an important dietary component, serving both as a source
of energy and as a supplier of essential FA. We have shown in
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trations of dietary fish oil alters circulating concentrations of FA
[9–13]. In general, the long-chain (n-3) polyunsaturated fatty acids
(PUFA) from fish oil are considered anti-inflammatory and
immunomodulatory [14]. At sufficient levels of incorporation,
eicosapentaenoic acid [EPA, 20:5 (n-3)] and docosahexaenoic acid
[DHA, 22:6 (n-3)] influence the physical nature of cell membranes
and membrane protein-mediated responses, lipid-mediator gener-
ation, cell signaling, and gene expression in many different cell
types [15]. The PUFA from fish oil, and in particular eicosanoids
derived from EPA, may protect against excessive inflammatory
reactions, which may be exacerbated by eicosanoids derived from
the (n-6) PUFA arachidonic acid [AA, 20:4 (n-6)]. There is some,
albeit limited, data to support the notion that (n-3) PUFA
ameliorate clinical symptoms in human patients with diseases
characterized by active inflammation [16]. In dogs, there is
evidence to suggest that (n-3) FA have beneficial effects in the
treatment of osteoarthritis [17].
The products of lipid digestion undergo an interesting journey
before they reach the bloodstream. First, lipolytic by-products are
solubilized in micelles within the intestinal lumen. They then
diffuse from the micelle across the enterocyte brush border
membrane and enter the cytoplasm of the cell. Within enterocytes,
triglycerides are resynthesized. The resynthesized triglycerides and
phospholipids, together with cholesterol are combined with
apoprotein to form chylomicrons. Chylomicrons leave the cell
by exocytosis and enter the lymph via the lacteals in the villi.
Finally, they reach the bloodstream via the thoracic duct.
Medium-chain triglycerides (MCT) contain intermediate chain
length FA, which are water soluble and can be absorbed directly
without depending on micelle formation. They also pass through
enterocytes without being resynthesized into triglycerides. They do
not take part in chylomicron formation and are absorbed directly
into the portal blood. The MCT also do not rely on carnitine for
transport across the inner mitochondrial membrane. The names of
the medium-chain FA (and the corresponding number of carbons)
found in MCT are caproic acid [C6:0], caprylic acid [C8:0],
capric acid [C10:0] and lauric acid [C12:0]. Coconut oil is
composed of approximately 66% MCT.
Previous human studies have shown that inclusion of 10% fish
oil in mixed medium- and long-chain triacylglycerol emulsions
increases plasma triacylglycerol clearance and induces rapid EPA
incorporation into blood-cell phospholipids [18]. The metabolism
of lipid emulsions is similar to that of chylomicrons with
intravascular lipolysis by lipoprotein lipase followed by tissue
uptake of remnant particles [19]. The fast hydrolysis of MCT
releases large amounts of medium-chain FA, which are rapidly
oxidized by many tissues sparing (n-3) FA from entering oxidative
pathways. Rapid lipolysis of MCT also leads to the formation of
small-sized remnant particles enriched with (n-3) FA that can be
readily taken up by endocytosis [20], allowing increased EPA and
DHA FA incorporation into membrane phospholipids [21].
The purpose of this study was to determine if dogs consuming a
complete and balanced adult-food base formula with added L-
carnitine, MCT, and (n-3) FA from fish oil are able to maintain
total-lean-body weight, total serum protein and albumin concen-
trations, and achieve desired alterations in serum FA profiles and
carnitine metabolite concentrations. We hypothesized that serum
carnitine and long chain (n-3) FA concentrations decrease with
age, and that these changes could be offset by nutritional
intervention. We were able to document age-related changes in
the PUFA to SFA ratio and in carnitine metabolite concentrations
that could be counterbalanced by dietary enrichment with these
compounds.
Materials and Methods
Dogs and Ethics Statement
The study protocol was reviewed and approved by the
Institutional Animal Care and Use Committee, Hill’s Pet
Nutrition, Inc., Topeka, KS, USA (Permit Number: 09-487). All
dogs were immunized against canine distemper, adenovirus,
parvovirus, bordetella, and rabies, and none had chronic systemic
disease on the basis of results of physical examination, complete
blood count determination, serum biochemical analyses, urinaly-
sis, and fecal examination for parasites. Dogs were housed in pairs
in indoor runs or in spacious rooms with natural light that varied
with seasonal changes. All dogs were exercised daily, and were
provided with regular opportunities for socialization and environ-
mental enrichment. Dogs experienced behavioral enrichment
through interactions with each other, by daily interaction and play
time with caretakers, and by daily opportunities to run and
exercise outside with access to toys.
Forty one healthy Beagle dogs with mean age of 9.9 years (range
3.1 to 14.8 years) were included in this study. Equal numbers of
females (n=21; ovariohysterectomized) and males (n=20; neu-
tered) were randomized to 3 study groups. Initial body weight,
mean 6 SEM, was 12.460.4 kg. Exclusion criteria included the
inability to eat dry food and/or any diagnosed disease condition.
The criterion for removal from the study was development of any
condition whereby removal would benefit the animal. Three
animals were removed during the study for unrelated reasons:
bladder carcinoma, surgery for intervertebral disc disease, and foot
abscess with fever. All other animals remained healthy and
completed the study.
To evaluate the influence of age, age categories were defined as
7 years and under (mature adults), or older than 7 years (geriatric
adults). This resulted in reasonably balanced groups at the end of
the study with 18 animals in the mature adult group (control food
n=5; food with increased (n-3) FA content n=8; food with
increased (n-3) and (n-6) FA food that was enriched in MCT n=5)
and 20 animals in the geriatric adult group (control food n=8;
food with increased (n-3) FA content n=4; food with increased (n-
3) and (n-6) FA food that was enriched in MCT n=8).
Foods
Prior to beginning the study, all dogs were consuming the same
non-test food for 30 days (Table 1). This pre-trial food was a
complete and balanced adult canine food [22], although relatively
low in fat.
Three test foods were prepared by Hill’s Pet Nutrition, Inc.: a
control food (Hill’sH Prescription DietH k/dH, Hill’s Pet Nutrition,
Inc.) and two foods with added L-carnitine but different
concentrations of FA. Both experimental foods were Prescription
DietH k/dH base food with added L-carnitine (300 mg/kg as fed)
and fish oil (0.6 or 1.5% as fed). The test food with 1.5% fish oil
and added MCT from coconut oil also had reduced AA because of
a reduction in animal fat in the formulation. The reduced animal
fat was replaced with plant oils (2% coconut oil and 7% corn oil).
Food composition of the three diets is summarized in Table 1.
All test foods contained similar concentrations (within analytical
variance of targets) of protein, fat, calcium, phosphorus, and
sodium, and were isocaloric. The control food lacked appreciable
quantities of long chain EPA and DHA, and medium-chain capric
[10:0], lauric [12:0], and myristic [14:0] FA. Control food was
richest in palmitic [16:0] and stearic [18:0] FA. Treatment food 1
was richer in EPA and DHA than control food, but comparable in
medium-chain FA content. Treatment food 2 contained increased
concentrations of EPA and DHA, as well as increased concentra-
Aged Dogs Fed MCT, Fish Oil, and Carnitine Foods
PLOS ONE | www.plosone.org 2 November 2012 | Volume 7 | Issue 11 | e49510tions of medium-chain FA, and linoleic [LA, 18:2 (n-6)] and a-
linolenic [aLA, 18:3 (n-3)] FA. Treatment food 2 also contained
the least amounts of palmitic, stearic, and AA FA. All foods had
relatively the same (n-6) to (n-3) FA ratio, which was approxi-
mately 2.3:1.
Study Design and Measurements
The study design was a three treatment study, whereby dogs
were fed either control food or one of two treatment foods. Study
duration was 6 months. All dogs had access to electronic feeders
where fresh food was offered daily with amounts calculated to
maintain body weight; water was available ad libitum. Daily food
intake (g/d) was recorded for each dog.
For each dog, data were collected initially and again after
consuming foods for one, three, and six months. Blood was
collected to measure serum biochemistries, serum FA concentra-
tions, and serum metabolomic profiles.
Fatty acid composition of the experimental foods was determined
by a commercial laboratory (Eurofins Scientific, Inc., Des Moines,
IA) by gas chromatography of FA methyl esters. Fatty acid
concentrations are expressed as g/100 g of FAs as fed. The sum of
dietary saturated fatty acids (SFA) was determined as follows:
8:0+10:0+11:0+12:0+14:0+15:0+16:0+17:0+18:0+20:0+22:0+24:0.
The sum of dietary monounsaturated fatty acids (MUFA) was
determined as follows: 14:1+15:1+16:1+17:1+18:1+20:1+22:1+24:1.
The sum of dietary PUFA was determined as follows: 18:2(n-6)+
Table 1. Food composition of pre-trial food, control food*, and two dietary treatment foods.
{
Pre-trial food Control Food
Increased (n-3)
FA Food
Increased (n-3) and
(n-6) FA Food
Added Fish Oil, % 0 0 0.6 1.5
Added L-carnitine, mg/kg 0 0 300 300
Added Coconut and
Corn Oils, (+,–)
––– +
Moisture 6.38 6.88 7.86 7.58
Protein 18.25 13.66 14.12 14.09
Fat 8.07 18.15 17.89 18.32
Atwater Energy
1 (kcal/kg) 3,484 3,960 3,921 3,959
Ash 4.20 3.90 4.38 3.97
Crude Fiber 1.4 2.0 1.3 1.5
Calcium 0.89 0.70 0.75 0.72
Phosphorus 0.73 0.28 0.31 0.29
Sodium 0.12 0.2 0.2 0.2
Capric acid [10:0] 0.00 0.00 0.01 0.12
Lauric acid [12:0] 0.00 0.01 0.01 0.87
Myristic acid [14:0] 0.05 0.17 0.18 0.46
Palmitic acid [16:0] 1.38 3.60 3.45 2.26
Stearic acid [18:0] 0.49 1.67 1.53 0.76
Arachidic acid [20:0] 0.02 0.03 0.03 0.04
LA [18:2 (n-6)] 2.10 3.07 3.09 4.61
aLA [18:3 (n-3)] 0.08 1.27 1.35 1.63
AA [20:4 (n-6)] 0.03 0.08 0.08 0.06
EPA [20:5 (n-3)] 0.00 0.01 0.10 0.23
DHA [22:6 (n-3)] 0.00 0.00 0.07 0.16
g SFA
£ 1.97 5.56 5.40 4.70
g MUFA
¥ 2.44 6.81 6.21 5.26
g PUFA
" 2.26 4.52 4.65 6.65
g (n-6) FA
# 2.17 3.22 3.15 4.59
g (n-3) FA
{ 0.09 1.30 1.49 2.06
(n-6):(n-3) ratio 24.11 2.48 2.11 2.23
*Prescription DietH k/dH, Hill’s Pet Nutrition, Inc.
{All analytical values are expressed as percentage of food as fed, unless otherwise indicated.
1Calculated from analyticals using modified Atwater numbers (kcal/g of 3.5 for protein, 8.5 for fat and 3.5 for nitrogen free extract).
£Sum of the saturated fatty acids: 8:0+10:0+11:0+12:0+14:0+15:0+16:0+17:0+18:0+20:0+22:0+24:0.
¥Sum of the monounsaturated fatty acids: 14:1+15:1+16:1+17:1+18:1+20:1+22:1+24:1.
"Sum of the polyunsaturated fatty acids: 18:2(n-6)+18:3(n-6)+18:3(n-3)+18:4(n-3)+20:2(n-6)+20:3(n-6)+20:3(n-3)+20:4(n-6)+20:4(n-3)+20:5(n-3)+21:5(n-3)+22:2(n-
6)+22:4(n-6)+22:5(n-6)+22:5(n-3)+22:6(n-3).
#Sum of the (n-6) fatty acids.
{Sum of the (n-3) fatty acids.
doi:10.1371/journal.pone.0049510.t001
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Fatty acid composition of serum samples was also determined
by gas chromatography of FA methyl esters, with minor
modifications [17] of the Folch et al. [23] method. Fatty acid
concentrations in serum, determined using this methodology, were
expressed as mg/dL.
Metabolomic profiles of serum samples were determined by a
commercial laboratory (Metabolon; Durham, NC) using a
proprietary solvent extraction method. Extracted supernatant
was split and run on gas chromatography and liquid chromatog-
raphy mass spectrometer platforms [24] in a randomized order.
Gas chromatography (for hydrophobic molecules) and liquid
chromatography (for hydrophilic molecules) were used to identify
and provide relative quantification of small metabolites present in
serum samples. Endogenous biochemicals included amino acids,
peptides, carbohydrates, lipids, (e.g., FA and lysophospholipids),
nucleotides, cofactors and vitamins, and xenobiotics. Data for each
individual compound were normalized by calculating the median
values for each run-day block (block normalization). This
minimized any inter-day instrument gain drift, but did not
interfere with intra-day sample variability. Missing values were
assumed to be below the level of detection for that compound with
the instrumentation used. Missing values (if any) were imputed
with the observed minimum for that particular compound.
Imputed values were added after block-normalization.
Changes in body mass and composition were assessed by dual-
energy x-ray absorptiometry (DXA-QDR-4500, Hologic, Inc.,
Waltham, MA) scan analysis initially and after six months of food
consumption. Data were analyzed by the software supplied by the
manufacturer. Total-, fat-, and lean-body mass were determined.
Statistical Analyses
The analyses for serum biomarkers and changes in body mass
and composition were performed using a repeated measures
regression model in Statistical Analysis Software version 9.2 (SAS
Institute, Cary, NC) for initial, final, and change between final and
initial concentrations. Mean separation was performed using
animal age, food formula and time on treatment as independent
variables. Significance was accepted as P#0.05, unless otherwise
specified.
For metabolomic data, serum values from the end of the pretrial
feeding period (day 0) were used such that each animal served as
its own control, and data are presented relative to day 0 as fold
change. All values were log-transformed prior to statistical
analysis. Welch’s two-way ANOVA and two-sample t-test analyses
were applied to log-transformed data. A q-value cutoff of 0.10 was
used. This value provides an estimate of the proportion of false
discoveries within each of the individual contrasts and based on
this, 10% of the compounds determined to be significant within
each of the individual contrasts may possibly represent false
positives. Main effects of animal age, diet, time, and diet by time
interaction, as well as t-test comparisons were considered
significant if P,0.05 and q,0.10. To investigate the relationship
between creatinine and carnitine moities, correlation coefficients
were measured between these response variables.
Results
The Effect of Dietary Treatment on Total-, Fat-, and Lean-
body Weights
There were no differences in average daily food intake among
dogs of the 3 dietary treatment groups. All dogs gained weight
after consuming the dietary treatment foods for 6 months
(P,0.01), but there were no differences in total-body weight gain
based on dietary treatment (Table 2). Total-fat-body weight
increased in dogs from all 3 treatment groups after 6 months of
food consumption. There were no changes in total-lean-body
weight after consuming the dietary treatment foods for 6 months
based on time or dietary treatment.
The Effect of Dietary Treatment on Selected Serum
Biochemistries
There was no decrease in serum total protein or serum albumin
concentrations after consuming dietary treatment foods for 6
months based on time or dietary treatment (Table 2). The
concentration of serum urea nitrogen decreased (P,0.01) in dogs
of all three treatment groups after 6 months of food consumption,
but there were no differences based on dietary treatment. The
change in serum creatinine concentrations across time (increased;
data not shown) in dogs consuming the increased (n-3) and (n-6)
FA food that was enriched in MCT, or experimental food with
increased (n-3) FA content alone, was greater (P,0.01 and
P=0.03, respectively) than the change across time in dogs
consuming control food (decreased). However, changes in serum
creatinine concentrations were within the reference interval and
biologically insignificant. Serum phosphorus concentrations in-
creased (P=0.03) in dogs of all three treatment groups after 6
months of food consumption, but there were no differences based
on dietary treatment. Again, changes in serum phosphorus
concentrations were within the reference interval and biologically
insignificant. Serum triglyceride concentrations approximately
doubled (P,0.01) in dogs of all three treatment groups after 6
months of food consumption, but there were no differences based
on dietary treatment. Serum cholesterol concentrations also
increased (P,0.01) in dogs of all three treatment groups after 6
months of food consumption, although the change across time
(data not shown) was less in dogs consuming the increased (n-3)
and (n-6) FA food that was enriched in MCT than in control dogs
(P=0.01) or dogs consuming experimental food with increased (n-
3) FA content alone (P=0.03).
The Effect of Dietary Treatment on Concentrations of FA
in Serum Determined by Gas Chromatography of FA
Methyl Esters
The FA composition of serum in dogs from all three treatment
groups at baseline (initial) were the same (Table 3). Subsequent
supplementation of food with 0.6 or 1.5% fish oil produced
proportionate increases in FA concentrations of EPA and DHA in
dogs consuming the two experimental foods. Dogs consuming test
food for 6 months with 1.5% fish oil, reduced AA, added MCT
from coconut oil, and added corn oil had greater increases in
serum lauric, myristic, and LA FA concentrations compared to
dogs consuming control food or food enriched with 0.6% fish oil.
These dogs also had decreased palmitic, palmitoleic, oleic and AA
FA concentrations.
Serum FA were grouped according to their degree of saturation
(sum of SFA, MUFA, and PUFA), and class of FA [sum of (n-3)
and (n-6) FA] (Table 3). Although the sum of serum (n-3) FA
increased with fish oil supplementation, the sum of serum PUFA
did not change based on dietary treatment. The sums of serum
SFA and PUFA both increased in dogs consuming control and
increased (n-3) FA foods; thus, the PUFA:SFA ratio was
unchanged. In dogs consuming increased (n-3) and (n-6) FA food
that was enriched in MCT, the increase in sum of serum PUFA
Aged Dogs Fed MCT, Fish Oil, and Carnitine Foods
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ratio increased (P,0.01).
The Effect of Dietary Treatment on Serum Metabolomic
Profiles
Carnitine and its metabolites that were significantly affected
within and among dogs maintained on the three test foods are
presented in Table 4. Serum carnitine levels were significantly
increased by dietary supplementation with 300 mg/kg as fed. In
addition, multiple carnitine metabolites (acetyl-, stearoyl-, propi-
onyl-, succinyl-, glutaroyl-, 2-methylbutyroyl-, and isovaleryl-
carnitine) increased with time (P,0.05) relative to baseline
concentrations in dogs receiving carnitine-supplemented diets.
However, the long-chain acylcarnitine (stearoyl-carnitine) was
significantly (P,0.05) increased over baseline only in dogs
receiving fish oil at the 0.6% supplementation rate with no added
MCT. Deoxycarnitine concentrations decreased across time in all
dog treatment groups (P,0.05). One carnitine metabolite (2-
methylbutyroylcarnitine) was positively correlated to creatinine
concentration (P,0.01).
Selected lysophospholipids from serum metabolomic profiles
that showed statistically significant differences among dogs
maintained on the three test foods are presented in Table 5.
Supplementation of food with fish oil affected concentrations of
several lysophopholipids. In particular, the glycerophosphoetha-
nolamines (GPE) 1-arachidonoyl- and 2-arachdidonoyl-GPE, but
also 1-linoleoyl- and 2-linoleoyl-GPE, showed significant dietary
treatment and time main effects. Of particular note, the two dog
groups receiving fish-oil supplementation showed decreased
concentrations across time. In contrast to the GPE, the
glycerophosphocholine (GPC) containing DHA (1-docosahexae-
Table 2. Body weight and composition indices, and selected serum biochemistries from serum biochemical profiles, of dogs at
baseline (initial) and after consuming control* or treatment foods for 194 days (mean 6 SEM).
Control Food
Increased (n-3)
FA Food
Increased
(n-3) and
(n-6) FA Food
Two-way ANOVA Analysis
(P values)
Number of Animals, N 13 12 13 Diet
Main Effect
Time Main
Effect
Diet by Time
Main Effect
Added Fish Oil, % 0 0.6 1.5
Added L-carnitine, mg/kg 0 300 300
Added Coconut and Corn Oils, Reduced
Animal Fat (+,–)
––+
Body weight and composition indices:
Total-body weight
{ (kg)
Initial
Final
11.8360.83
12.6560.87
12.5360.51
13.5560.54
13.0060.55
13.7760.57
,0.01
Total-fat-body weight
{ (g)
Initial
Final
34066165
45066281
37816169
49006185
44266316
51086286
,0.01
Total-lean-body weight
{ (g)
Initial
Final
80326688
78436651
83466516
83016533
82716437
83216446
Serum biochemistries:
Albumin (mg/dL)
Initial
Final
3.4660.08
3.5360.07
3.5360.07
3.5760.06
3.4960.06
3.6260.05
Total Protein (mg/dL)
Initial
Final
5.6560.09
5.7060.08
5.7360.11
5.7860.07
5.7160.06
5.8660.07
Urea Nitrogen (mg/dL)
Initial
Final
9.8860.68
7.9660.50
10.2360.65
7.7360.54
10.6160.58
8.2560.41
,0.01
Creatinine (mg/dL)
Initial
Final
0.6660.05
0.6360.04
0.6160.05
0.6860.06
0.6660.04
0.7960.05
Phosphorous (mg/dL)
Initial
Final
3.4860.20
4.3660.19
3.8860.22
4.3160.25
3.6660.22
4.0960.29
0.03
Triglycerides (mg/dL)
Initial
Final
100633
195618
88614
236630
73615
184613
,0.01
Cholesterol (mg/dL)
Initial
Final
18769
23569
205610
250620
201611
21767
,0.01
*PrescriptionDietH k/dH, Hill’s Pet Nutrition, Inc.
{Body mass and composition were determined by dual-energy X-ray absorptiometry scan analysis.
doi:10.1371/journal.pone.0049510.t002
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Its concentration was dramatically increased across time although
it was significantly greater in dogs receiving 0.6% vs. 1.5% fish oil
supplementation rate in a reverse dose-response manner. There
was no effect of dietary treatment or time on glyceropho-
sphoinositol concentrations (data not shown).
Table 4. Carnitine metabolites of dogs after consuming control* or treatment foods for 194 days.
{
Control Food
Increased (n-3)
FA Food
Increased
(n-3) and (n-6)
FA Food
Two-way ANOVA Analysis
(P values)
Number of Animals, N 13 12 13 Diet Main
Effect
Time Main
Effect
Diet by Time
Main Effect
Added Fish Oil, % 0 0.6 1.5
Added L-carnitine, mg/kg 0 300 300
Added Coconut and Corn Oils, Reduced
Animal Fat (+,–)
–– +
Carnitine 0.71
a 1.22
b 1.12 ,0.10 ,0.05
Deoxy-carnitine 0.95 0.95 0.89 ,0.05
Acetyl-carnitine 1.08 1.57
a 1.48
a ,0.05 ,0.05
Stearoyl-carnitine 1.49 4.00
a 0.84 ,0.05 ,0.05
Propionyl-carnitine 1.22 1.58
a 1.85
a ,0.05 ,0.05
Succinyl-carnitine 1.04 1.25
a 1.39
a ,0.05 ,0.10
Glutaroyl-carnitine 1.36
a 1.62
a 1.63
a ,0.05
2-methylbutyroyl-carnitine 1.10 2.03
a 1.87
a ,0.05 ,0.05
Isovaleryl-carnitine 0.99 1.71
a 1.84
a ,0.05 ,0.05 ,0.05
Hydroxyisovaleroyl-carnitine 0.90
b 1.01 1.02
*PrescriptionDietH k/dH, Hill’s Pet Nutrition, Inc.
{Using serum values from baseline, each animal served as its own control. Data are presented relative to baseline as fold change. All data were log-transformed prior to
statistical analysis.
aIndicates significantly increased or decreased fold-change between the diet group shown and baseline at P,0.05.
bIndicates fold-change values that are trends but missed the significant cutoff (P.0.05, P,0.10).
doi:10.1371/journal.pone.0049510.t004
Table 5. Lysophospholipids of dogs after consuming control* or treatment foods for 194 days.
{
Control Food
Increased (n-3)
FA Food
Increased
(n-3) and (n-6)
FA Food
Two-way ANOVA Analysis
(P values)
Number of Animals, N 13 12 13 Diet Main
Effect
Time Main
Effect
Diet by Time
Main Effect
Added Fish Oil, % 0 0.6 1.5
Added L-carnitine, mg/kg 0 300 300
Added Coconut and Corn Oils, Reduced
Animal Fat (+,–)
–– +
1-linoleoyl-glycerophosphoethanolamine 0.81 0.72
a 0.98 ,0.05
2-linoleoyl-glycerophosphoethanolamine 0.87
a 0.85
b 0.97 ,0.05 ,0.05
1-arachidonoyl-glycerophosphoethanolamine 0.96 0.78
b 0.65
a ,0.05 ,0.05
2-arachidonoyl-glycerophosphoethanolamine 0.85 0.76
b 0.92 ,0.05 ,0.10
1-arachidonoyl-glycerophosphocholine 1.75 0.96 1.06
2-arachidonoyl-glycerophosphocholine 1.80 2.05 0.81
1-docosahexaenoyl-glycerophosphocholine 1.73
b 3.77
a 2.79
a ,0.05 ,0.05
*PrescriptionDietH k/dH, Hill’s Pet Nutrition, Inc.
{Using serum values from baseline, each animal served as its own control. Data are presented relative to baseline as fold change. All data were log-transformed prior to
statistical analysis.
aIndicates significantly increased or decreased fold-change between the diet group shown and baseline at P,0.05.
bIndicates fold-change values that are trends but missed the significant cutoff (P.0.05, P,0.10).
doi:10.1371/journal.pone.0049510.t005
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At baseline, the ratio for geriatric to mature adults dogs of
PUFA to SFA ratios was significantly decreased (P,0.05; Table 6)
because the ratio of PUFA to SFA in mature dogs was greater than
for geriatric dogs. This was most likely because the concentrations
of SFA were greater in geriatric dogs (not significant at P,0.05).
No other significant differences were noted at baseline for relative
ratios of serum concentrations of FA in geriatric vs. mature dogs.
There was no age by diet interaction; hence FA concentrations for
mature or geriatric dogs consuming the three test foods were
combined across time. At the end of the study, the increases
associated with supplemented food were much greater than the
increases associated with younger age. None-the-less, increasing
age was significantly associated with decreasing serum EPA
(P,0.05), DHA (P,0.10), and sum of the (n-3) FA (P,0.10)
concentrations (Table 6).
At baseline, the relative concentration ratios for geriatric to
mature adult dogs were less than one for carnitine and most
carnitine metabolite concentrations. Succinyl-carnitine and 2-
methylbutyroyl-carnitine were significantly decreased in dogs over
7 years of age (P,0.05; Table 6) as were deoxy-carnitine and
acetyl-carnitine at P,0.10. There was no age by diet interaction;
hence serum carnitine and its metabolite concentrations for
mature or geriatric dogs consuming the three test foods were
combined across time. Increasing age was significantly (P,0.05)
associated with decreasing serum succinyl-carnitine, 2-methylbu-
tyroyl-carnitine, and hydroxyisovaleroyl-carnitine concentrations,
whereas deoxy-carnitine, propionyl-carnitine, and glutaroyl-car-
nitine concentrations were decreased at P,0.10 (Table 6). There
was no statistically significant increase in any carnitine metabolite
concentration as a result of age.
Adding dietary MCT, fish oil, and L-carnitine attenuated the
normal effects of aging on circulating concentrations of these
supplemented FA (Table 3) in that FA concentrations were all
increased as a result of supplementation. The PUFA to SFA ratio
Table 6. Relative ratios of serum concentrations of selected fatty acids and carnitine metabolites in geriatric dogs (.7 yr) vs.
mature adult dogs (#7 yr) at baseline (initial) and after consuming control* or treatment foods for 194 days.
Relative Concentration Ratios
{ for Geriatric to Mature Adult Dogs
Initial
(Baseline)
Final
(After 194 Days) Combined
1
Fatty Acids:
g SFA
£ 1.01 0.96 0.98
g MUFA
¥ 0.92 0.99 0.96
LA [18:2 (n-6)] 0.98 1.04 1.01
cLA [18:3 (n-6)] 1.02 0.97 0.99
aLA [18:3 (n-3)] 0.97 1.00 0.99
AA [20:4 (n-6)] 0.96 0.91 0.94
EPA [20:5 (n-3)] 0.90 0.94 0.93
a
DHA [22:6 (n-3)] 1.13
b 0.91
b 0.94
b
g PUFA
" 0.98 0.98 0.98
PUFA:SFA ratio 0.97
a 1.02
a 1.00
g (n-6)FA
# 0.98 0.98 0.98
g(n-3)FA
{ 0.99 0.94 0.95
b
(n-6):(n-3) FA ratio 0.99 1.08 1.01
Carnitine Metabolites:
Carnitine 0.95 1.09 1.02
Deoxy-carnitine 0.90
b 0.95 0.92
b
Acetyl-carnitine 0.96
b 0.94 0.95
Stearoyl-carnitine 0.94 1.31 1.17
Propionyl-carnitine 0.89 1.00 0.96
b
Succinyl-carnitine 0.81
a 0.87
a 0.84
a
Glutaroyl-carnitine 0.95 0.85
b 0.89
b
2-methylbutyroyl-carnitine 0.78
a 0.95 0.88
a
Isovaleryl-carnitine 1.12 1.25 1.20
Hydroxyisovaleroyl-carnitine 0.76 0.78 0.77
a
{The ratios are the average concentration of an analyte for dogs in the geriatric group divided by average concentration of the same analyte for dogs in the mature
adult group.
1Because there was no age by diet interaction, concentrations for dogs consuming different diets are combined across time.
aThere was a significant effect of age on these ratios (P#0.05).
bThere was an effect of age on these ratios (P.0.05, P,0.10).
*
,£, ¥, ",#,{ See Table 1 for rest of key.
doi:10.1371/journal.pone.0049510.t006
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increased (n-3) and (n-6) FA food that was enriched in MCT,
mainly because the SFA concentrations did not increase as they
did in dogs consuming control food or experimental food with
increased (n-3) FA content alone. Adding L-carnitine to the food
counterbalanced the effects of aging on circulating concentrations
of most carnitine metabolites in that fold change relative to
baseline was significantly greater than one (P,0.05; Table 4).
Discussion
All Foods Maintained Total-lean-body Weight and
Biomarkers of Protein Adequacy
Canine Prescription DietH k/dH was used as the control food
and base formula for treatment foods in this study. It has reduced
protein (13.5% as fed), phosphorus, and sodium concentrations
compared to other canine maintenance foods, and contains
greater levels of non-protein calories (18.0% fat; 56.9% carbohy-
drate). For comparison, Science DietH Canine AdultH has 23.0%
protein, 14.2% fat, and 49.0% carbohydrate. Animal feeding tests
using AAFCO [22] procedures substantiate that Canine k/dH
provides complete and balanced nutrition for maintenance of
adult dogs. In the current study, all dogs maintained total- and
lean-body weight, serum total protein and serum albumin
concentrations. All values were within normal ranges for adult
dogs [25]. These results support the findings of a previous study
[26] that this diet provides adequate protein nutrition for
maintenance of adults dogs.
Adding Specific FA to the Diet Changed those FA in
Circulation
The ratio of PUFA to SFA was significantly greater in mature
dogs compared with geriatric dogs at baseline, likely because SFA
concentrations were greater in geriatric dogs. The pre-trial food
was relatively low in fat, including (n-3) FA, compared to test foods
such that other FA differences between age groups at baseline
were not detectable. Adding 1.5% fish oil plus MCT to the food
significantly increased the ratio of PUFA to SFA in all dogs, with
the net effect that all dogs looked more like younger dogs. Younger
dogs were more efficient at increasing (n-3) FA concentrations
than older dogs, as evidenced by the relative ratios of serum (n-3)
FA concentrations in geriatric vs. mature adult dogs being less
than one at the end of the study. Adding 0.6 or 1.5% fish oil
produced proportionate increases in serum FA concentrations of
EPA and DHA in dogs consuming the two treatment foods. Fatty
acid changes determined by metabolomic analysis of serum
confirmed FA changes determined by gas chromatography of
FA methyl esters (data not shown). These results reflect the effect
of dietary dose rather than ratio of (n-6) to (n-3) FA on serum FA
concentrations, and are consistent with what we found in previous
studies [9,12]. In previous studies the addition of 2% fish oil to the
diet reduced the relative abundance of serum AA and LA in dogs.
In the current study, the addition of 0.6% dietary fish oil increased
serum EPA and DHA concentrations, but was not associated with
a concomitant decrease in serum AA or LA. Adding 1.5% fish oil
plus coconut and corn oils to the food decreased serum AA in
dogs, but increased LA concentrations compared to those of dogs
eating control food.
Adding 1.5% fish oil plus MCT to the food caused small albeit
significant increases in serum lauric [12:0] and myristic [14:0] FA,
but much larger decreases in palmitic [16:0], palmitoleic [16:1]
and oleic [18:1] FA concentrations. Stearic acid [18:0] concen-
trations increased in dogs of all treatment groups, with significantly
greater concentrations in dogs consuming treatment food supple-
mented with 0.6% fish oil.
It is difficult to determine from our results whether MCT were
hydrolyzed more quickly, sparing the (n-3) FA from entering
oxidative pathways. Highly unsaturated FA are favored for
esterification into phospholipids, which makes them more
abundant in phosphoglycerides than in triacylglycerols and makes
analysis of phospholipids a preferred approach for evaluating
highly unsaturated FA contents [27]. In our study, however, we
did not fractionate plasma lipids into subclasses prior to analysis.
In our study, the ratio of MCT to fish oil was approximately
1.33. In the Simoens et al. [18] study of parenteral nutrition, lipid
emulsions were 50% MCT, 40% long-chain triacylglycerol, and
10% fish oil (wt:wt:wt). In the Carpentier et al. [20] study, the
emulsions were 80% MCT and 20% fish oil. The content of (n-3)
PUFA was assessed in plasma, leukocyte and platelet phospholip-
ids in both of these human studies, and infusion of MCT:fish oil
emulsions allowed rapid enrichment of cells with (n-3) PUFAs.
Studzinski et al. [28] reported that greater rates of FA oxidation
were achieved in aged dogs by exogenously adding MCT to their
normal diet. A structured triglyceride containing 95% caprylic
acid [C8:0] and 5% capric acid [C10:0] was added to the food and
fed at 2 g/kg body weight in their study. In a follow up study,
Taha et al. [21] showed that dietary enrichment with MCT
increased DHA concentrations in brain total lipids, phospholipids,
and unesterified FA in aged dogs. Because the MCT supplement
did not contain PUFA, the increase in DHA was likely due to
tissue redistribution from adipose to brain. Although we did not
measure FA oxidation or tissue incorporation of FA in our study,
increased DHA concentrations in dogs fed 1.5% fish oil and MCT
may reflect increased dietary DHA as well as spared oxidation of
DHA by dietary MCT. Future studies are needed to control for
the amount of added fish oil in the presence of MCT.
Adding Dietary Carnitine Increased Serum Carnitine and
its Metabolites
At baseline, several of the serum carnitine metabolite concen-
trations were significantly decreased in geriatric dogs. We found
that supplementing with L-carnitine resulted in increased concen-
trations of circulating carnitine metabolites to counterbalance the
effects of aging. Younger dogs were more efficient at increasing
carnitine metabolite concentrations than older dogs, as evidenced
by the number of statistically significant relative concentration
ratios that were less than one at the end of the study.
The acylation state of carnitine in serum reflects the compo-
sition of the cytosolic acylcarnitine pool, and thus, the equilibrium
between acyl-CoA and acylcarnitine species. Future studies in dogs
are needed to determine if maintaining circulating concentrations
of carnitine metabolites long term confers age-related health
benefits. For example, a recent study assessing the impact of
acylcarnitine acyl chain length showed that longer acyl chain
length significantly predicts poorer physical function and worsened
anemia in dialysis patients [29].
Serum Docosahexaenoyl-glycerophosphocholine (DHA-
GPC) Concentration was Increased by Feeding Fish Oil
Phospholipids are major constituents of biological membranes.
Membrane lipids are constantly synthesized and degraded
(metabolic turnover) via a collection of specific hydrolases stored
in lysosomes, including phospholipase A1 and A2. These hydro-
lases remove FA from membrane glycerophospholipids; these FA
are then used in the synthesis of eicosanoids. Eicosanoids derived
from EPA are considered less inflammatory than those derived
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one FA removed, is called a lysophospholipid; these metabolites
are biologically important as well.
Previously, we reported that serum concentrations of DHA-
GPC were significantly increased in a dose-response manner in
Beagle dogs following dietary fish oil enrichment [13]. Those
lysophospholipid results were in agreement with the notion that
DHA is incorporated into inflammatory cell phospholipids, partly
at the expense of AA. A clinical trial in humans also showed that
plasma EPA- and DHA-lysophosphatidylcholine concentrations
were significantly increased with EPA/DHA supplementation
[30]. In the current study, serum DHA-GPC was increased by
feeding fish oil, but the addition of MCT attenuated the dose-
response relationship. The mechanism of these relationships
remains unknown.
In the immune system, lysophospholipid signaling may have
anti-inflammatory roles through modulating cytokines, lipid
mediators, and transcription factors in epithelial cells [31]. Thus,
DHA-GPC may express anti-inflammatory activity through
multiple actions, including suppression of nitric oxide, TNF-a
inhibition of 5-lipoxygenase activity, as well as via formation of
maresin or protectin D via a series of metabolic activation
pathways. Of major importance, Huang et al. [32] showed that
the diverse properties of the GPC class of lysophospholipids are
highly dependent on the type of FA attached to the GPC. Hung
et al. [33] suggested that 2-DHA-GPC may be more efficient than
1-DHA-GPC as an anti-inflammatory agent when administered
orally to mice. DHA migrates very easily from the sn-2 position of
GPC, which could be considered as the physiological form of
DHA-GPC, to the sn-1 position, which is much more stable [34].
Kono et al. [35] have shown that enteral diets enriched with
both (n-3) FA and MCT are superior to diets enriched with (n-3)
FA alone for the therapy of chemically induced colitis in rats.
Together they inhibit the expression of inflammatory cytokines/
chemokines in the colonic tissue, the production of those mediators
by activated macrophages, and the accumulation of activated
neutrophils in the colon, all of which ameliorated colonic injury.
Creatinine Concentrations were Increased in Older Dogs
and in Dogs Consuming Treatment Foods, but Remained
within the Normal Reference Interval
In the absence of dehydration, circulating creatinine concen-
tration is often used as an indicator of glomerular filtration rate,
and by extrapolation, a marker to assess renal function. There was
a significant positive correlation between circulating creatinine
concentration and total-lean-body weight. When this relationship
was used as a covariate, circulating creatinine concentrations were
increased in older dogs. We also showed a small but significant
increase in circulating creatinine concentration in dogs consuming
treatment foods. Although there was a significant correlation
between 2-methylbutyroyl carnitine and creatinine, we found no
effect of changing circulating concentrations of carnitine or its
metabolites on creatinine concentrations.
In conclusion, supplementation of dogs with L-carnitine, MCT,
and EPA and DHA FA counterbalanced changes in these serum
biochemistries as dogs aged, although younger dogs were more
efficient in their accrual. Importantly, changes in circulating
metabolites were not associated with any detectable change in
renal function in healthy dogs with normal creatinine concentra-
tions.
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